Table of Contents
ID Biomedical
ID Biomedical is a Canadian subsidiary of GlaxoSmithKline based in Sainte-Foy, Quebec.1)
The company was dedicated to the manufacturing and development of innovative vaccine products, including influenza vaccines.2)
History
Formerly based in Vancouver, British Columbia, the company was bought by GSK in 2005 for $1.7 billion.3)
1)
Health Canada. (2014, July 21). Summary Report - ID Biomedical Corporate of Quebec (GSK). Government of Canada. https://web.archive.org/web/20220428153830/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/summary-report-biomedical-corporate-quebec.html
2)
FOI Request - HTH-2015-51828. (2016, February 12). Government of British Columbia. https://web.archive.org/web/20220428045844/http://docs.openinfo.gov.bc.ca/Response_Package_HTH-2015-51828.pdf
3)
GlaxoSmithKline buys Vancouver’s ID Biomedical for $1.7 billion. (2005, September 7). CBC News. https://www.cbc.ca/news/business/glaxosmithkline-buys-vancouver-s-id-biomedical-for-1-7-billion-1.534195